These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 2654285
1. Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study. Morgan MY, Alonso M, Stanger LC. J Hepatol; 1989 Mar; 8(2):208-17. PubMed ID: 2654285 [Abstract] [Full Text] [Related]
2. Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study. Morgan MY, Hawley KE, Stambuk D. J Hepatol; 1987 Apr; 4(2):236-44. PubMed ID: 3295020 [Abstract] [Full Text] [Related]
3. Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial. Morgan MY, Hawley KE. Hepatology; 1987 Apr; 7(6):1278-84. PubMed ID: 3315932 [Abstract] [Full Text] [Related]
5. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Gluud LL, Vilstrup H, Morgan MY. Cochrane Database Syst Rev; 2016 May 06; 2016(5):CD003044. PubMed ID: 27153247 [Abstract] [Full Text] [Related]
9. Lactitol in prevention of recurrent episodes of hepatic encephalopathy in cirrhotic patients with portal-systemic shunt. Riggio O, Balducci G, Ariosto F, Merli M, Pieche U, Pinto G, Tremiterra S, Ziparo V, Capocaccia L. Dig Dis Sci; 1989 Jun 06; 34(6):823-9. PubMed ID: 2656134 [Abstract] [Full Text] [Related]
11. Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy. Patil DH, Westaby D, Mahida YR, Palmer KR, Rees R, Clark ML, Dawson AM, Silk DB. Gut; 1987 Mar 06; 28(3):255-9. PubMed ID: 3570029 [Abstract] [Full Text] [Related]
12. Lactitol or lactulose in the treatment of chronic hepatic encephalopathy: results of a meta-analysis. Blanc P, Daures JP, Rouillon JM, Peray P, Pierrugues R, Larrey D, Gremy F, Michel H. Hepatology; 1992 Feb 06; 15(2):222-8. PubMed ID: 1531204 [Abstract] [Full Text] [Related]
13. [A clinical comparative study of crystalline pure lactulose and powder pure lactitol in portasystemic encephalopathy of cirrhotic patients]. Grandi M, Sacchetti C, Pederzoli S, Celani MF. Minerva Gastroenterol Dietol; 1991 Feb 06; 37(4):225-30. PubMed ID: 1805974 [Abstract] [Full Text] [Related]
15. Nonabsorbable disaccharides for hepatic encephalopathy. Als-Nielsen B, Gluud LL, Gluud C. Cochrane Database Syst Rev; 2004 Feb 06; (2):CD003044. PubMed ID: 15106187 [Abstract] [Full Text] [Related]
16. Effects of long-term administration of low-dose lactitol in patients with cirrhosis but without overt encephalopathy. Salerno F, Moser P, Maggi A, Vitaliani G, Benetti G. J Hepatol; 1994 Dec 06; 21(6):1092-6. PubMed ID: 7699233 [Abstract] [Full Text] [Related]
17. Treatment of porto-systemic encephalopathy with lactitol verus lactulose: a randomized controlled study. Pai CH, Huang YS, Jeng WC, Chan CY, Lee SD. Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jan 06; 55(1):31-6. PubMed ID: 7712392 [Abstract] [Full Text] [Related]
19. Enterococcus lactic acid bacteria strain SF68 and lactulose in hepatic encephalopathy: a controlled study. Loguercio C, Del Vecchio Blanco C, Coltorti M. J Int Med Res; 1987 Jan 06; 15(6):335-43. PubMed ID: 3125077 [Abstract] [Full Text] [Related]